Ester Neurosciences Overview
- Year Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$15M
Ester Neurosciences General Information
Description
Developer of therapeutic products for the treatment of neurological disorders. The company provides novel therapeutic products for the treatment of neurological disorders such as myasthenia gravis, alzheimer disease, multiple sclerosis and acute stress reactions.
Contact Information
Corporate Office
- Ackerstein Towers, Building B
- 10th Floor, 11 Hamanofim Street
- Herzliya 46725
- Israel
Corporate Office
- Ackerstein Towers, Building B
- 10th Floor, 11 Hamanofim Street
- Herzliya 46725
- Israel
Ester Neurosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Dec-2007 | $15M | Completed | Clinical Trials - Phase 2 | ||
| 1. Early Stage VC | Completed |
Ester Neurosciences Patents
Ester Neurosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2007237059-A1 | Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases | Active | 10-Apr-2006 | ||
| AU-2007237059-B2 | Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases | Inactive | 10-Apr-2006 | ||
| CA-2648980-A1 | Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases | Inactive | 10-Apr-2006 | ||
| EP-2007399-A2 | Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases | Inactive | 10-Apr-2006 | ||
| US-20090275634-A1 | Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases | Inactive | 10-Apr-2006 | C12N15/1137 |
Ester Neurosciences Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medica Venture Partners | Venture Capital | Minority |
Ester Neurosciences FAQs
-
When was Ester Neurosciences founded?
Ester Neurosciences was founded in 1997.
-
Where is Ester Neurosciences headquartered?
Ester Neurosciences is headquartered in Herzliya, Israel.
-
What industry is Ester Neurosciences in?
Ester Neurosciences’s primary industry is Other Devices and Supplies.
-
Is Ester Neurosciences a private or public company?
Ester Neurosciences is a Private company.
-
What is the current valuation of Ester Neurosciences?
The current valuation of Ester Neurosciences is .
-
What is Ester Neurosciences’s current revenue?
The current revenue for Ester Neurosciences is .
-
Who are Ester Neurosciences’s investors?
Medica Venture Partners has invested in Ester Neurosciences.
-
When was Ester Neurosciences acquired?
Ester Neurosciences was acquired on 01-Dec-2007.
-
Who acquired Ester Neurosciences?
Ester Neurosciences was acquired by Amarin Corporation.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process